Erdafitinib
Erdafitinib is a potent and selective orally bioavailable, pan fibroblast growth factor receptor (FGFR) inhibitor with potential antineoplastic activity. It inhibits FGFR1/2/3/4 with IC₅₀s of 1.2, 2.5, 3.0 and 5.7 nM, respectively.
Product Specifications
Shipping Conditions
Gel Pack
Storage Conditions
-20ºC
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6124804 1.0 µg DNA
Ap3s1 sgRNA CRISPR Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details 